European Health Catapult 2020 winners announced on final day of EIT Health Summit Series
15 December 2020
The fourth and final live day of the EIT Health Summit Series 2020 saw the exciting conclusion of the European Health Catapult, a training competition programme that sees some of the brightest European health start-ups pitching for essential support and funding.
The programme is now its fifth year and since 2016 has seen:
This year’s competition, presented by Kurt Höller, Director of Business Creation, saw 42 start-ups selected from across Europe to compete in three categories; Medtech, Biotech and Digital Health. 21 made it through to the semi-finals, before nine start-ups were selected for the live final, where they were invited to pitch to a panel of industry experts and investors.
Prizes of €40,000 (for first place), €20,000 (for second place) and €10,000 (for third place) are awarded to three winners in each of the categories: Biotech, Medtech and Digital, as well as €800,000 in in-kind support from sponsors including Nasdaq, Amazon Web Services, L3S Partnership, Virdis Group, Lallianse and McDermott Will & Emery.
In the Digital Health category
‘Methinks AI’took first place for its solution of using imaging technology to reduce time to treatment in stroke patients where every second counts. ‘Popit’ took second place for its sensor technology to improve patients’ adherence to medicines, and ‘PatchAI’ was awarded third place for its digital solution to improve compliance in clinical trials.
In the Medtech category
‘New Born Solutions’ was awarded first place for its solution to improve the detection of infectious diseases such as meningitis in new-borns. ‘STIL’ came in second place for its solution to reduce tremour in patients such as those with Parkinson’s disease, and 'Gradient' was awarded third place for its minimally invasive product to treat pulmonary hypertension.
In the Biotech category
‘UVera’ was awarded first place (as well as the Alex Casta Audience Award, which is voted on live by the EIT Health Catapult audience during the EIT Health Summit) for its solution to provide natural, safe, potent, stable and eco-friendly UV protection. In second place was ‘PhagoMed’ whose solution uses a synthetic biology platform to precisely target any bacterial pathogen, and in third place was ‘Gelmetix’ who is developing bio-inductive gels that modify cell behaviour to treat patients suffering from chronic lower back pain and osteoarthritis.
Don’t worry if you missed the live session, you can watch the recording here.